Difference between revisions of "Category:REMS program"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
These are drugs that are considered to be particularly dangerous by the FDA. Prescription of these drugs requires enrollment in their respective [http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm Risk Evaluation and Mitigation Strategy (REMS) programs] to help manage risk. Links to every medication's REMS program are on each drug-specific page below.
 
These are drugs that are considered to be particularly dangerous by the FDA. Prescription of these drugs requires enrollment in their respective [http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm Risk Evaluation and Mitigation Strategy (REMS) programs] to help manage risk. Links to every medication's REMS program are on each drug-specific page below.
 +
 +
[[Category:FDA approved drugs]]
 +
[[Category:Clinical pharmacology]]

Latest revision as of 16:16, 29 September 2020

These are drugs that are considered to be particularly dangerous by the FDA. Prescription of these drugs requires enrollment in their respective Risk Evaluation and Mitigation Strategy (REMS) programs to help manage risk. Links to every medication's REMS program are on each drug-specific page below.